NET PROFIT (x1000 DKK)
EMPLOYEES
ERCO Pharma AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-2,028
|
-3,321
|
-2,470 |
| EBITDA |
-2,004
|
-3,296
|
-2,309 |
| Total assets |
75
|
768
|
194 |
| Current assets |
75
|
744
|
140 |
| Current liabilities |
38
|
734
|
156 |
| Equity capital |
37
|
35
|
38 |
| - share capital |
34
|
33
|
36 |
| Employees (average) |
2
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
49.3%
|
4.6%
|
19.6% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-2704.0%
|
-432.4%
|
-1273.2% |
| Current ratio |
197.4%
|
101.4%
|
89.7% |
| Return on equity (ROE) |
-5481.1%
|
-9488.6%
|
-6500% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-33%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.